オルソバイオロジクス市場：タイプ、用途、エンドユーザー別-2025-2030年の世界予測

オルソバイオロジクス市場は、2023年に66億1,000万米ドルと評価され、2024年には70億5,000万米ドルに達すると予測され、CAGR 6.73％で成長し、2030年には104億3,000万米ドルに達すると予測されています。

オルソバイオロジクスでは、筋骨格系の傷害や症状の治癒を助けるために生物学的物質を使用し、成長因子、タンパク質、幹細胞などの天然成分を利用して回復を促進します。この分野は、主に整形外科やスポーツ医学の分野で応用され、身体が本来持っている治癒プロセスを強化するように設計された製品を包含しています。オルソバイオロジクスの必要性は、特に人口の高齢化や骨関連疾患の増加に伴い、より迅速な回復と治療成績の向上を提供する低侵襲治療に対する需要の高まりから生じています。これらの生物製剤は、骨移植、脊椎固定、軟骨再生などの場面で応用されており、エンドユーザーは病院、専門クリニック、外来手術センターなどに及んでいます。

市場成長の原動力は、技術の進歩、研究開発投資の増加、従来の方法よりも新しい再生療法を好む患者の増加です。ヘルスケアにおけるバイオテクノロジーの統合は、大きなビジネスチャンスをもたらしています。特に、幹細胞研究と生体材料工学の革新は、製品開発の画期的な可能性を秘めています。しかし、市場の拡大は、高いコスト、規制上のハードル、特に幹細胞の使用に関する倫理的配慮などの課題に直面しています。生物製剤の製造は複雑であり、厳しい承認プロセスも相まって、参入や製品開発への大きな障壁となっています。

企業にとっては、個別化医療に焦点を当てた革新的技術で製品ポートフォリオを強化し、費用対効果が高くスケーラブルな生産方法を開発することに大きな機会があります。学術機関との提携に投資し、政府出資の研究プロジェクトを活用することで、製品開発と承認までの時間を短縮することができます。技術革新の主要分野には、送達メカニズムの改善、バイオアベイラビリティの向上、適応症の拡大などがあります。市場のダイナミックな性質は、急速な技術進歩や規制基準の進化によって特徴づけられるため、戦略立案には機敏さが求められます。企業は、規制状況を効率的にナビゲートするための戦略主導型調査に注力し、市場情勢のメリットや用途に関する認知度を高める教育イニシアティブに投資することで、最終的に市場の需要を促進する必要があります。

市場力学：急速に進化するオルソバイオロジクス市場の主要市場インサイトを公開

オルソバイオロジクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • さまざまな疾病に罹患しやすい世界中の老人人口の急増
  • オルソバイオロジクスに対する意識の高まり
  • 肥満の急増、スポーツ事故や交通事故の増加
• 市場抑制要因
  • オルソバイオロジクスの高価格化
• 市場機会
  • 発展途上国における高い成長性
  • 高度治療への需要の高まり
• 市場の課題
  • 厳しい承認プロセス

ポーターの5つの力：オルソバイオロジクス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：オルソバイオロジクス市場における外部からの影響の把握

外部マクロ環境要因は、オルソバイオロジクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析オルソバイオロジクス市場における競合情勢の把握

オルソバイオロジクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスオルソバイオロジクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、オルソバイオロジクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨オルソバイオロジクス市場における成功への道筋を描く

オルソバイオロジクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • さまざまな病気にかかりやすい高齢者人口が世界中で急増
    • オルソバイオロジクスの認知度の向上
    • 肥満の急増、スポーツ事故や交通事故の増加
  • 抑制要因
    • オルソバイオロジクスのコストが高い
  • 機会
    • 発展途上国における高い成長の可能性
    • 高度な治療の需要の高まり
  • 課題
    • 厳格な承認プロセス
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 オルソバイオロジクス市場：タイプ別

• 同種移植
• 骨形成タンパク質
• 脱灰骨マトリックス
• 関節液療法
• 軟部組織の修復
• 幹細胞療法
• 人工骨移植

第7章 オルソバイオロジクス市場：用途別

• 骨折の回復
• 再建手術
• 軟部組織損傷
• 脊椎固定術
• 外傷の修復

第8章 オルソバイオロジクス市場：エンドユーザー別

• 歯科医院と施設
• 病院
• 調査・学術機関

第9章 南北アメリカのオルソバイオロジクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のオルソバイオロジクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのオルソバイオロジクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Arthrex, Inc.
• Bioventus LLC
• DePuy Synthes
• Globus Medical, Inc.
• Harvest Technologies Corporation
• Kuros Biosciences Ltd.
• Nuvasive, Inc.
• Orthofix International N.V.
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. ORTHOBIOLOGICS MARKET RESEARCH PROCESS
• FIGURE 2. ORTHOBIOLOGICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ORTHOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ORTHOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ORTHOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ORTHOBIOLOGICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ORTHOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ORTHOBIOLOGICS MARKET DYNAMICS
• TABLE 7. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENIC PROTEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY DEMINERALISED BONE MATRIX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY JOINT FLUID THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SOFT TISSUE REPAIR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY FRACTURE RECOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SOFT-TISSUE INJURIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY DENTAL CLINICS & FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. CANADA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. CANADA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. CHINA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. CHINA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. CHINA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. INDIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. INDIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. INDIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. INDONESIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. JAPAN ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. MALAYSIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. PHILIPPINES ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. SINGAPORE ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. SOUTH KOREA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. TAIWAN ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. THAILAND ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. VIETNAM ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. DENMARK ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. EGYPT ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. FINLAND ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. FRANCE ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. GERMANY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. ISRAEL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. ITALY ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. ITALY ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. ITALY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NETHERLANDS ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. NIGERIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. NORWAY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. POLAND ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. POLAND ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. POLAND ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. QATAR ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. QATAR ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. QATAR ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. RUSSIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SAUDI ARABIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH AFRICA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SPAIN ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. SWEDEN ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. SWITZERLAND ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. TURKEY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. UNITED ARAB EMIRATES ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. ORTHOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 153. ORTHOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

The Orthobiologics Market was valued at USD 6.61 billion in 2023, expected to reach USD 7.05 billion in 2024, and is projected to grow at a CAGR of 6.73%, to USD 10.43 billion by 2030.

Orthobiologics involves the use of biological substances to aid in the healing of musculoskeletal injuries and conditions, harnessing natural components such as growth factors, proteins, and stem cells to facilitate recovery. This sector encompasses products designed to enhance the body's innate healing processes, with applications primarily in orthopedic and sports medicine contexts. The necessity of orthobiologics arises from the growing demand for minimally invasive treatments that offer quicker recovery and improved outcomes, particularly with aging populations and increasing incidences of bone-related disorders. These biologics are applied in scenarios such as bone grafting, spinal fusion, and cartilage regeneration, with end users spanning hospitals, specialty clinics, and ambulatory surgical centers.

Market growth is driven by advances in technology, increased investment in R&D, and a heightened patient preference for novel regenerative therapies over traditional methods. The integration of biotechnology in healthcare has opened substantial opportunities; particularly, innovations in stem cell research and biomaterial engineering are potential groundbreakers for product development. However, market expansion faces challenges including high costs, regulatory hurdles, and ethical considerations, notably concerning stem cell usage. The complexity of biologics production, coupled with stringent approval processes, presents significant barriers to entry and product development.

For businesses, significant opportunities lie in enhancing product portfolios with innovations focused on personalized medicine and developing cost-effective and scalable production methods. Investing in partnerships with academic institutions and leveraging government-funded research projects can accelerate product development and approval times. Key areas of innovation include improving delivery mechanisms, enhancing bioavailability, and expanding indications for use. The market's dynamic nature is characterized by rapid technological advancements and evolving regulatory standards, necessitating agility in strategic planning. Companies should focus on strategy-driven research to navigate regulatory landscapes efficiently and invest in educational initiatives that raise awareness of the benefits and applications of orthobiologics, ultimately driving market demand.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Orthobiologics Market

The Orthobiologics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Surge in geriatric population across the globe prone with various diseases
  • Increase in awareness of orthobiologics
  • Surge in obesity and rise in number of sports accidents and road accidents
• Market Restraints
  • Higher cost of orthobiologics
• Market Opportunities
  • High growth potential in developing nations
  • Upsurge in demand for advanced treatment
• Market Challenges
  • Stringent approval process

Porter's Five Forces: A Strategic Tool for Navigating the Orthobiologics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Orthobiologics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Orthobiologics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Orthobiologics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Orthobiologics Market

A detailed market share analysis in the Orthobiologics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Orthobiologics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Orthobiologics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Orthobiologics Market

A strategic analysis of the Orthobiologics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Orthobiologics Market, highlighting leading vendors and their innovative profiles. These include Arthrex, Inc., Bioventus LLC, DePuy Synthes, Globus Medical, Inc., Harvest Technologies Corporation, Kuros Biosciences Ltd., Nuvasive, Inc., Orthofix International N.V., Stryker Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Orthobiologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Allografts, Bone Morphogenic Proteins, Demineralised Bone Matrix, Joint Fluid Therapy, Soft Tissue Repair, Stem Cell Therapies, and Synthetic Bone Grafts.
• Based on Application, market is studied across Fracture Recovery, Reconstructive Surgery, Soft-Tissue Injuries, Spinal Fusion, and Trauma Repair.
• Based on End-User, market is studied across Dental Clinics & Facilities, Hospitals, and Research & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Surge in geriatric population across the globe prone with various diseases
    • 5.1.1.2. Increase in awareness of orthobiologics
    • 5.1.1.3. Surge in obesity and rise in number of sports accidents and road accidents
  • 5.1.2. Restraints
    • 5.1.2.1. Higher cost of orthobiologics
  • 5.1.3. Opportunities
    • 5.1.3.1. High growth potential in developing nations
    • 5.1.3.2. Upsurge in demand for advanced treatment
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent approval process
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Orthobiologics Market, by Type

• 6.1. Introduction
• 6.2. Allografts
• 6.3. Bone Morphogenic Proteins
• 6.4. Demineralised Bone Matrix
• 6.5. Joint Fluid Therapy
• 6.6. Soft Tissue Repair
• 6.7. Stem Cell Therapies
• 6.8. Synthetic Bone Grafts

7. Orthobiologics Market, by Application

• 7.1. Introduction
• 7.2. Fracture Recovery
• 7.3. Reconstructive Surgery
• 7.4. Soft-Tissue Injuries
• 7.5. Spinal Fusion
• 7.6. Trauma Repair

8. Orthobiologics Market, by End-User

• 8.1. Introduction
• 8.2. Dental Clinics & Facilities
• 8.3. Hospitals
• 8.4. Research & Academic Institutes

9. Americas Orthobiologics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Orthobiologics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Orthobiologics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Arthrex, Inc.
• 2. Bioventus LLC
• 3. DePuy Synthes
• 4. Globus Medical, Inc.
• 5. Harvest Technologies Corporation
• 6. Kuros Biosciences Ltd.
• 7. Nuvasive, Inc.
• 8. Orthofix International N.V.
• 9. Stryker Corporation
• 10. Zimmer Biomet Holdings, Inc.